“…S ince its inception, AE&M aimed to establish itself as a leading source of highquality scientific information in the areas of endocrinology and metabolism (1). In that sense, maintaining open access to our articles was paramount to amplify the reach of such information in a globalized, albeit inequitable, world (2). Aiming to continue to serve the community of readers, authors, and reviewers in the best possible way, two new implementations are underway: AE&M has joined PubMed Central (PMC), and from May 2023, AE&M will adopt the continuous publication model.…”